Pascal Girard Selected Research

Pascal Girard Research Topics

Disease

12	Neoplasms (Cancer) 12/2023 - 09/2009
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2009
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 01/2021
3	Body Weight (Weight, Body) 01/2023 - 01/2020
3	Merkel Cell Carcinoma 01/2022 - 01/2019
3	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2011 - 01/2007
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2023
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2023
2	Multiple Sclerosis 12/2022 - 12/2022
2	Edema (Dropsy) 01/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2012 - 10/2009
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2023
1	Peritoneal Neoplasms 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Nausea 01/2020
1	Vomiting 01/2020
1	Fatigue 01/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2012
1	Sickle Cell Anemia (Hemoglobin S Disease) 05/2011
1	Nonseminomatous germ cell tumor 08/2010
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 08/2010
1	Lymphoma (Lymphomas) 10/2009
1	Prostatic Neoplasms (Prostate Cancer) 09/2009
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2008
1	Angina Pectoris 08/2002
1	Stable Angina 08/2002

Drug/Important Bio-Agent (IBA)

4	avelumabIBA 01/2022 - 01/2019
4	tepotinibIBA 01/2022 - 01/2020
4	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2018
4	Capecitabine (Xeloda)FDA Link 01/2018 - 09/2009
3	AlbuminsIBA 01/2023 - 01/2019
2	pembrolizumabIBA 12/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2023
2	evobrutinibIBA 12/2022 - 12/2022
2	Lipase (Acid Lipase)FDA Link 01/2022 - 01/2020
2	B7-H1 AntigenIBA 01/2020 - 01/2019
2	Monoclonal AntibodiesIBA 01/2020 - 01/2007
2	Rituximab (Mabthera)FDA Link 04/2012 - 10/2009
2	Therapeutic UsesIBA 02/2012 - 08/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2011 - 12/2010
1	Prostaglandins AIBA 01/2023
1	IpilimumabIBA 01/2023
1	NivolumabIBA 01/2023
1	LigandsIBA 01/2023
1	TACI receptor-IgG Fc fragment fusion proteinIBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2022
1	TransferasesIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Amylases FDA Link 01/2022
1	C-Reactive ProteinIBA 01/2022
1	CreatinineIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	Serum AlbuminIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	PlatinumIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Hydroxyurea (Hydrea)FDA LinkGeneric 05/2011
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 08/2010
1	Tumor Biomarkers (Tumor Markers)IBA 08/2010
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2010
1	Fluorouracil (Carac)FDA LinkGeneric 09/2009
1	Etoposide (VP 16)FDA LinkGeneric 11/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2007
1	InterleukinsIBA 01/2007
1	inolimomabIBA 01/2007
1	IvabradineIBA 08/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 08/2010
2	Therapeutics 01/2023 - 12/2020
2	Drug Tapering 01/2022 - 02/2012
1	Premedication 11/2023
1	Immunotherapy 01/2023
1	Induction Chemotherapy 01/2022
1	Hematopoietic Stem Cell Transplantation 03/2011
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2011
1	Prostatectomy (Retropubic Prostatectomy) 09/2009